101184-08-1,MFCD00127080
Catalog No.:AA0003TM

101184-08-1 | Methyl 4-(1h-imidazol-1-yl)benzenecarboxylate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$10.00   $7.00
- +
1g
98%
in stock  
$24.00   $17.00
- +
5g
98%
in stock  
$73.00   $51.00
- +
10g
98%
in stock  
$119.00   $83.00
- +
25g
98%
in stock  
$228.00   $160.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0003TM
Chemical Name:
Methyl 4-(1h-imidazol-1-yl)benzenecarboxylate
CAS Number:
101184-08-1
Molecular Formula:
C11H10N2O2
Molecular Weight:
202.2093
MDL Number:
MFCD00127080
SMILES:
COC(=O)c1ccc(cc1)n1ccnc1
Properties
Computed Properties
 
Complexity:
225  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
15  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
3  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.5  

Synonyms
 
  
Upstream Synthesis Route

[1]Patent:KR101502187,2015,B1,.Locationinpatent:Paragraph0384;0385

[2]JournalofMedicinalChemistry,1990,vol.33,#4,p.1091-1097

[3]Patent:US4804662,1989,A,

[1]Synthesis(Germany),2017,vol.49,#6,p.1223-1230

[2]SyntheticCommunications,2012,vol.42,#17,p.2595-2605

[1]Patent:CN105348327,2016,A,.Locationinpatent:Paragraph0055;0057;0058

[2]ChemicalCommunications,2016,vol.52,#69,p.10505-10508

[1]Molecules,2016,vol.21,#7,

[1]TetrahedronLetters,2015,vol.56,#7,p.889-892

Downstream Synthesis Route

[1]Patent:KR101502187,2015,B1.Locationinpatent:Paragraph0384;0385

[2]JournalofMedicinalChemistry,1990,vol.33,p.1091-1097

[3]Patent:US4804662,1989,A

[1]JournalofMedicinalChemistry,1990,vol.33,p.1091-1097

[1]JournalofMedicinalChemistry,1990,vol.33,p.1091-1097

[1]JournalofMedicinalChemistry,1990,vol.33,p.2883-2891

50-00-0   
4-2-Oxo-eth-(Z)-ylideneamino-benzoicacidmethylester 
  101184-08-1 

[1]Synthesis,2003,p.2661-2666

Literature

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
Country:
Additional Info:
SDS
Tags:101184-08-1 Molecular Formula|101184-08-1 MDL|101184-08-1 SMILES|101184-08-1 Methyl 4-(1h-imidazol-1-yl)benzenecarboxylate
Catalog No.: AA0003TM
101184-08-1,MFCD00127080
101184-08-1 | Methyl 4-(1h-imidazol-1-yl)benzenecarboxylate
Pack Size: 250mg
Purity: 98%
in stock
$10.00 $7.00
Pack Size: 1g
Purity: 98%
in stock
$24.00 $17.00
Pack Size: 5g
Purity: 98%
in stock
$73.00 $51.00
Pack Size: 10g
Purity: 98%
in stock
$119.00 $83.00
Pack Size: 25g
Purity: 98%
in stock
$228.00 $160.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0003TM
Chemical Name: Methyl 4-(1h-imidazol-1-yl)benzenecarboxylate
CAS Number: 101184-08-1
Molecular Formula: C11H10N2O2
Molecular Weight: 202.2093
MDL Number: MFCD00127080
SMILES: COC(=O)c1ccc(cc1)n1ccnc1
Properties
Complexity: 225  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 15  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 3  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.5  
52:   
Upstream Synthesis Route
288-32-4    403-33-8    101184-08-1 

[1]Patent:KR101502187,2015,B1,.Locationinpatent:Paragraph0384;0385

[2]JournalofMedicinalChemistry,1990,vol.33,#4,p.1091-1097

[3]Patent:US4804662,1989,A,

288-32-4    99768-12-4    101184-08-1 

[1]Synthesis(Germany),2017,vol.49,#6,p.1223-1230

[2]SyntheticCommunications,2012,vol.42,#17,p.2595-2605

288-32-4    619-42-1    101184-08-1 

[1]Patent:CN105348327,2016,A,.Locationinpatent:Paragraph0055;0057;0058

[2]ChemicalCommunications,2016,vol.52,#69,p.10505-10508

288-32-4    619-44-3    101184-08-1 

[1]Molecules,2016,vol.21,#7,

67-56-1    10040-98-9    101184-08-1 

[1]TetrahedronLetters,2015,vol.56,#7,p.889-892

Downstream Synthesis Route
288-32-4    403-33-8    101184-08-1 

[1]Patent:KR101502187,2015,B1.Locationinpatent:Paragraph0384;0385

[2]JournalofMedicinalChemistry,1990,vol.33,p.1091-1097

[3]Patent:US4804662,1989,A

14165-27-6    101184-08-1    120690-04-2 

[1]JournalofMedicinalChemistry,1990,vol.33,p.1091-1097

91015-20-2    101184-08-1    120690-01-9 

[1]JournalofMedicinalChemistry,1990,vol.33,p.1091-1097

101184-08-1    107-15-3    125903-44-8 

[1]JournalofMedicinalChemistry,1990,vol.33,p.2883-2891

50-00-0   
4-2-Oxo-eth-(Z)-ylideneamino-benzoicacidmethylester 
  101184-08-1 

[1]Synthesis,2003,p.2661-2666

Literature fold

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Building Blocks More >
1013405-24-7
1013405-24-7
2,6-Bis(3-(9h-carbazol-9-yl)phenyl)pyridine
AA00046Z | MFCD20275106
10148-69-3
10148-69-3
(2S,3R)-2-Amino-3-hydroxyhexanoic acid
AA0004IF | MFCD09842073
1015846-00-0
1015846-00-0
1-(2-(Trifluoromethyl)benzyl)-1H-pyrazol-5-amine
AA0004TF | MFCD08457376
1016776-39-8
1016776-39-8
5-Benzoxazolamine, 2-(1-methylethyl)-
AA000549 | MFCD09934235
1017969-32-2
1017969-32-2
7-Hydroxyquinoline-4-carboxylic acid
AA0005ID | MFCD11847889
1019108-35-0
1019108-35-0
Ethyl 2-amino-5,6-dihydro-4H-cyclopenta[d]thiazole-4-carboxylate
AA0005U4 | MFCD09864118
102-53-4
102-53-4
Methanediamine, N,N,N',N'-tetraethyl-
AA00065Q | MFCD00015115
10203-58-4
10203-58-4
Diethyl isobutylmalonate
AA0006C3 | MFCD00026869
10215-25-5
10215-25-5
3,6-Thioxanthenediamine-10,10-dioxide
AA0006OP | MFCD00041841
102281-45-8
102281-45-8
(2R)-2-Amino-3-(4-aminophenyl)propanoic acid hydrate
AA00070H | MFCD08276892
Submit
© 2017 AA BLOCKS, INC. All rights reserved.